Cargando…

SARS-CoV2 Testing: The Limit of Detection Matters

Resolving the COVID-19 pandemic requires diagnostic testing to determine which individuals are infected and which are not. The current gold standard is to perform RT-PCR on nasopharyngeal samples. Best-in-class assays demonstrate a limit of detection (LoD) of ~100 copies of viral RNA per milliliter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arnaout, Ramy, Lee, Rose A., Lee, Ghee Rye, Callahan, Cody, Yen, Christina F., Smith, Kenneth P., Arora, Rohit, Kirby, James E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302192/ https://www.ncbi.nlm.nih.gov/pubmed/32577640 http://dx.doi.org/10.1101/2020.06.02.131144

Ejemplares similares

The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing
por: Arnaout, Ramy, et al.
Publicado: (2021)

Nasal-Swab Testing Misses Patients with Low SARS-CoV-2 Viral Loads
por: Callahan, Cody, et al.
Publicado: (2020)

Nasal Swab Performance by Collection Timing, Procedure, and Method of Transport for Patients with SARS-CoV-2
por: Callahan, Cody, et al.
Publicado: (2021)

Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture
por: Stanley, Sydney, et al.
Publicado: (2022)

Reply to Li et al., “Kappa Values in Testing the Concordance: Comments on a Recent Article about Nasopharyngeal Swabs for SARS-CoV-2 Detection”
por: Callahan, Cody, et al.
Publicado: (2022)

Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2
por: Callahan, Cody, et al.
Publicado: (2021)

Open Development and Clinical Validation of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck
por: Callahan, Cody J., et al.
Publicado: (2020)

Open Development and Clinical Validation Of Multiple 3D-Printed Sample-Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck
por: Callahan, Cody J, et al.
Publicado: (2020)

Repertoire-scale measures of antigen binding
por: Arora, Rohit, et al.
Publicado: (2022)

Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus
por: Cheng, Annie, et al.
Publicado: (2022)

Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort
por: Kirby, James E., et al.
Publicado: (2023)

Advantages and Limitations of Anticipating Laboratory Test Results from Regression- and Tree-Based Rules Derived from Electronic Health-Record Data
por: Mohammad, Fahim, et al.
Publicado: (2014)

Visualizing omicron: COVID-19 deaths vs. cases over time
por: Arnaout, Ramy, et al.
Publicado: (2022)

The Future of Blood Testing Is the Immunome
por: Arnaout, Ramy A., et al.
Publicado: (2021)

Specificity and overlap in gene segment-defined antibody repertoires
por: Arnaout, Ramy A
Publicado: (2005)

Cooperation under Pressure: Lessons from the COVID-19 Swab Crisis
por: Arnaout, Ramy A.
Publicado: (2021)

Disease Prevalence Matters: Challenge for SARS-CoV-2 Testing
por: Lau, Chin-Shern, et al.
Publicado: (2021)

Fast and accurate view classification of echocardiograms using deep learning
por: Madani, Ali, et al.
Publicado: (2018)

The Landscape of Inappropriate Laboratory Testing: A 15-Year Meta-Analysis
por: Zhi, Ming, et al.
Publicado: (2013)

Robust estimates of overall immune-repertoire diversity from high-throughput measurements on samples
por: Kaplinsky, Joseph, et al.
Publicado: (2016)

Rapid antigen tests for SARS-CoV-2
por: Liu, Michael, et al.
Publicado: (2021)

Five Antigen Tests for SARS-CoV-2: Virus Viability Matters
por: Homza, Miroslav, et al.
Publicado: (2021)

Modeling the effectiveness of olfactory testing to limit SARS-CoV-2 transmission
por: Larremore, Daniel B., et al.
Publicado: (2021)

Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, Benin
por: Yadouleton, Anges, et al.
Publicado: (2021)

Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings
por: Bandawe, Gama, et al.
Publicado: (2022)

Customized care 2020: how medical sequencing and network biology will enable personalized medicine
por: Boguski, Mark S, et al.
Publicado: (2009)

HO-1 and CD39: It Takes Two to Protect the Realm
por: Lee, Ghee Rye, et al.
Publicado: (2019)

Retrospective Analysis of Nosocomial SARS-CoV-2 Infections in Orthopedic and Traumatological Inpatients
por: Dankl, Lukas, et al.
Publicado: (2023)

Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based Perspective
por: Schildgen, Verena, et al.
Publicado: (2021)

A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings
por: Frew, Erica, et al.
Publicado: (2021)

State of the Globe: Navigating the Impact of SARS-CoV-2 Mutations on COVID-19 Testing
por: Varshney, Rohit Kumar
Publicado: (2023)

Proteases and variants: context matters for SARS-CoV-2 entry assays
por: Stevens, Christian S, et al.
Publicado: (2021)

SARS-CoV-2 in children and their accompanying caregivers: Implications for testing strategies in resource limited hospitals
por: Smit, Liezl, et al.
Publicado: (2022)

The Origin of Sars-CoV-2: Why It Matters
por: Vineis, Paolo, et al.
Publicado: (2021)

Challenges and issues of SARS-CoV-2 pool testing
por: Lee, Jaehyeon, et al.
Publicado: (2020)

Large-Scale, In-House Production of Viral Transport Media To Support SARS-CoV-2 PCR Testing in a Multihospital Health Care Network during the COVID-19 Pandemic
por: Smith, Kenneth P., et al.
Publicado: (2020)

Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic
por: Smith, Kenneth P., et al.
Publicado: (2020)

Limited Recognition of Highly Conserved Regions of SARS-CoV-2
por: Swaminathan, Srividhya, et al.
Publicado: (2022)

Tale of the Titers: Serologic Testing for SARS-CoV-2—Yes, No, and Maybe, With Clinical Examples From the IDSA Diagnostics Committee
por: Colgrove, Robert, et al.
Publicado: (2022)

Reduction in laboratory turnaround time decreases emergency room length of stay
por: Kaushik, Nitin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4uhecf4pekph7jjbb1krh91bi0